JP2013540803A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013540803A5 JP2013540803A5 JP2013535462A JP2013535462A JP2013540803A5 JP 2013540803 A5 JP2013540803 A5 JP 2013540803A5 JP 2013535462 A JP2013535462 A JP 2013535462A JP 2013535462 A JP2013535462 A JP 2013535462A JP 2013540803 A5 JP2013540803 A5 JP 2013540803A5
- Authority
- JP
- Japan
- Prior art keywords
- tnf
- antagonist
- pharmaceutical composition
- composition according
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1018325.9A GB201018325D0 (en) | 2010-10-30 | 2010-10-30 | Treatment for dupuytren's disease |
| GB1018325.9 | 2010-10-30 | ||
| GBGB1018362.2A GB201018362D0 (en) | 2010-11-01 | 2010-11-01 | Treatment of dupuytren's disease |
| GB1018362.2 | 2010-11-01 | ||
| GBGB1113718.9A GB201113718D0 (en) | 2011-08-10 | 2011-08-10 | Treatment of Dupuytren's Disease |
| GB1113718.9 | 2011-08-10 | ||
| PCT/EP2011/069147 WO2012056044A1 (en) | 2010-10-30 | 2011-10-31 | Treatment for dupuytren's disease |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016166524A Division JP2017014266A (ja) | 2010-10-30 | 2016-08-29 | デュピュイトラン病の治療 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013540803A JP2013540803A (ja) | 2013-11-07 |
| JP2013540803A5 true JP2013540803A5 (OSRAM) | 2014-12-18 |
| JP6004494B2 JP6004494B2 (ja) | 2016-10-12 |
Family
ID=44913268
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013535462A Active JP6004494B2 (ja) | 2010-10-30 | 2011-10-31 | デュピュイトラン病の治療 |
| JP2016166524A Pending JP2017014266A (ja) | 2010-10-30 | 2016-08-29 | デュピュイトラン病の治療 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016166524A Pending JP2017014266A (ja) | 2010-10-30 | 2016-08-29 | デュピュイトラン病の治療 |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US9138458B2 (OSRAM) |
| EP (1) | EP2632446B1 (OSRAM) |
| JP (2) | JP6004494B2 (OSRAM) |
| AU (2) | AU2011322482B2 (OSRAM) |
| CA (1) | CA2847197C (OSRAM) |
| DK (1) | DK2632446T3 (OSRAM) |
| ES (1) | ES2715204T3 (OSRAM) |
| RU (1) | RU2013123796A (OSRAM) |
| WO (1) | WO2012056044A1 (OSRAM) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012056044A1 (en) | 2010-10-30 | 2012-05-03 | Imperial Innovations Ltd | Treatment for dupuytren's disease |
| BR112014027347A2 (pt) | 2012-05-01 | 2017-06-27 | Proteolease Ltd | método para extrair um dente em um sujeito com essa necessidade, método para substituir um dente com um implante dentário e kit para extrair um dente |
| WO2013169382A1 (en) * | 2012-05-07 | 2013-11-14 | DePuy Synthes Products, LLC | Methods and devices for treating intervertebral disc disease |
| US20160158325A1 (en) * | 2013-07-11 | 2016-06-09 | 180 Therapeutics Lp | Method of treating fibroproliferative disorders including dupuytren's disease with one or more specific human matrix metalloproteinase and a tnf antagonist |
| AU2016226415B2 (en) * | 2015-03-02 | 2021-09-09 | 180 Therapeutics Lp | Method of treating a localized fibrotic disorder using a TNF receptor 2 antagonist |
| US12344667B2 (en) * | 2016-04-08 | 2025-07-01 | 180 Therapeutics Lp | Method of treating early stage Dupuytren's disease |
| US20190202907A1 (en) * | 2016-09-02 | 2019-07-04 | 180 Therapeutics Lp | Method of treating systemic fibrotic disorders using an il-33/tnf bispecific antibody |
| WO2018045210A1 (en) * | 2016-09-02 | 2018-03-08 | Therapeutics Lp 180 | Method of treating localized fibrotic disorders using an il-33/tnf bispecific antibody |
| US11564963B2 (en) | 2017-11-22 | 2023-01-31 | Progeneron, Llc | Topical compositions, process of large-scale manufacture, and method of use |
| EP3980022B1 (en) | 2019-06-07 | 2025-01-15 | Dale Biotech, LLC | Treatment of dupuytren's disease, osteoarthritis, or adhesive capsulitis with rhamnolipids. |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0939121T4 (da) * | 1989-09-12 | 2008-02-04 | Ahp Mfg B V | TNF-bindende proteiner |
| US5656272A (en) * | 1991-03-18 | 1997-08-12 | New York University Medical Center | Methods of treating TNF-α-mediated Crohn's disease using chimeric anti-TNF antibodies |
| GB9405076D0 (en) * | 1994-03-16 | 1994-04-27 | Inst Of Ophtalmology | A medical use of matrix metalloproteinase inhibitors |
| US6486140B2 (en) | 1994-07-19 | 2002-11-26 | Medicarb Ab | Agents, and methods employing them, for the prevention or reduction of tissue adhesion at a wound site |
| US5589171A (en) | 1994-08-22 | 1996-12-31 | Advance Biofactures Of Curacao | Treatment of Dupuytren's disease with collagenase |
| US6090382A (en) * | 1996-02-09 | 2000-07-18 | Basf Aktiengesellschaft | Human antibodies that bind human TNFα |
| CN1083337C (zh) | 1996-03-26 | 2002-04-24 | 精工爱普生株式会社 | 打印装置及其控制方法 |
| US6086872A (en) | 1997-03-27 | 2000-07-11 | Advance Biofactures Of Curacao, Nv | Amelioration of dupuytren's disease |
| US6031005A (en) * | 1998-08-03 | 2000-02-29 | Easterling; W. Jerry | Composition and method for treating Peyronie's disease and related connective tissue disorders |
| US6060474A (en) * | 1998-11-05 | 2000-05-09 | New York Society For The Relief Of The Ruptured And Crippled Maintaining The Hospital For Special Surgery | Method for preventing scar tissue formation |
| GB0105330D0 (en) | 2001-03-02 | 2001-04-18 | Renovo Ltd | Genetic testing |
| US7754217B2 (en) * | 2001-03-16 | 2010-07-13 | Bio3 Research Srl | HMGB1 protein inhibitors and/or antagonists for the treatment of vascular diseases |
| WO2002087576A1 (en) * | 2001-04-30 | 2002-11-07 | Arachnova Therapeutics Ltd. | The treatment of scarring and related conditions using ppar-gamma activators |
| DE60327075D1 (de) | 2002-07-05 | 2009-05-20 | Univ Laval | Der entzündungsreaktionen |
| GB0306165D0 (en) | 2003-03-18 | 2003-04-23 | Delta G Ltd | Medical treatment |
| US20080025986A1 (en) * | 2003-06-06 | 2008-01-31 | Ozes Osman N | Methods of Treating Tnf-Mediated Disorders |
| JP2007519756A (ja) * | 2004-01-30 | 2007-07-19 | アンジオテック インターナショナル アーゲー | 拘縮を治療するための組成物および方法 |
| KR20090130158A (ko) * | 2005-01-21 | 2009-12-17 | 더 리서치 파운데이션 오브 스테이트 유니버시티 오브 뉴욕 | 유착 관절낭염을 치료하는 방법 |
| US7431927B2 (en) * | 2005-03-24 | 2008-10-07 | Epitomics, Inc. | TNFα-neutralizing antibodies |
| AU2010221213B2 (en) | 2009-03-06 | 2014-10-23 | Kenneth William Gregg | Composition for controlling fish |
| WO2010102262A1 (en) | 2009-03-06 | 2010-09-10 | Halozyme, Inc. | Temperature sensitive mutants of matrix metalloprotease 1 und uses thereof |
| WO2012056044A1 (en) | 2010-10-30 | 2012-05-03 | Imperial Innovations Ltd | Treatment for dupuytren's disease |
-
2011
- 2011-10-31 WO PCT/EP2011/069147 patent/WO2012056044A1/en not_active Ceased
- 2011-10-31 AU AU2011322482A patent/AU2011322482B2/en active Active
- 2011-10-31 CA CA2847197A patent/CA2847197C/en active Active
- 2011-10-31 EP EP11779628.4A patent/EP2632446B1/en active Active
- 2011-10-31 ES ES11779628T patent/ES2715204T3/es active Active
- 2011-10-31 US US13/882,262 patent/US9138458B2/en active Active
- 2011-10-31 JP JP2013535462A patent/JP6004494B2/ja active Active
- 2011-10-31 RU RU2013123796/15A patent/RU2013123796A/ru not_active Application Discontinuation
- 2011-10-31 DK DK11779628.4T patent/DK2632446T3/en active
-
2015
- 2015-09-11 US US14/852,442 patent/US10273296B2/en active Active
-
2016
- 2016-08-29 JP JP2016166524A patent/JP2017014266A/ja active Pending
-
2017
- 2017-06-23 AU AU2017204267A patent/AU2017204267B2/en active Active
-
2019
- 2019-04-30 US US16/399,547 patent/US10669334B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013540803A5 (OSRAM) | ||
| EA201270221A1 (ru) | Лечение болезни крона с применением лаквинимода | |
| UA107578C2 (uk) | Комбінована терапія при лікуванні діабету | |
| WO2009021521A3 (en) | Use of gaboxadol for the manufacture of a medicament for treating stress-mediated depression | |
| MX2010004281A (es) | Composiciones y metodos para el tratamiento de la retinopatia diabetica. | |
| MX2012002082A (es) | Terapia de acetato de glatiramero de baja frecuencia. | |
| EA201290171A1 (ru) | Вводимые перорально кортикостероидные композиции | |
| BR112014006684A2 (pt) | análogos de glucagon | |
| EA201891154A1 (ru) | Ингибиторы рециклинга желчных кислот при лечении холестатических заболеваний печени у детей | |
| RU2013123796A (ru) | Способ лечения болезни дюпюитрена | |
| EA201300121A1 (ru) | Ингибитор дпп-4 в комбинации с дополнительным противодиабетическим агентом, таблетки, включающие указанные композиции, их применение и способ их получения | |
| HK1199726A1 (en) | Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof | |
| WO2009093119A3 (en) | Use of serine protease inhibitors in the treatment of skin diseases | |
| MX2012000275A (es) | Antagonista de bomba de acido para el tratamiento de enfermedades involucradas en la motilidad gastrointestinal anormal. | |
| BR112015010396A2 (pt) | terapia de combinação | |
| EA201490163A1 (ru) | Ингибиторы кинуренин-3-монооксигеназы, фармацевтические композиции и способы их применения | |
| EA201790406A1 (ru) | Ингибиторы кинуренин-3-монооксигеназы, фармацевтические композиции и способы их применения | |
| NZ606765A (en) | Combination pharmaceutical composition and methods of treating functional diseases or conditions of gastrointestinal tract | |
| WO2012007159A3 (en) | Novel gastro-retentive dosage forms | |
| EA200700214A1 (ru) | Мемантин в качестве дополнительной терапии к атипичным антипсихотическим средствам у больных шизофренией | |
| BR112012030641A2 (pt) | métodos e composições para terapia farmacêutica oral | |
| ATE470151T1 (de) | Diagnose, behandlung und prävention von gefässerkrankungen mittels il-1alpha- autoantikörpern | |
| AR081925A1 (es) | Uso de ranolazina para el tratamiento de la hipertension pulmonar | |
| RU2015127834A (ru) | Способы лечения диабета путем введения антагониста рецептора глюкагона в сочетании с ингибитором поглощения холестерина | |
| MX342020B (es) | Apolipoproteina a-iv como un peptido antidiabetico. |